Dyne Therapeutics Yönetim
Yönetim kriter kontrolleri 2/4
Dyne Therapeutics CEO'su John Cox, Mar2024 tarihinde atandı, in görev süresi bir yıldan az. şirketin hisselerinin 0.036% doğrudan sahiptir ve bu hisselerin değeri $ 1.09M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.4 yıl ve 5 yıldır.
Anahtar bilgiler
John Cox
İcra Kurulu Başkanı
n/a
Toplam tazminat
CEO maaş yüzdesi | n/a |
CEO görev süresi | less than a year |
CEO sahipliği | 0.04% |
Yönetim ortalama görev süresi | 3.4yrs |
Yönetim Kurulu ortalama görev süresi | 5yrs |
Son yönetim güncellemeleri
Recent updates
We're Hopeful That Dyne Therapeutics (NASDAQ:DYN) Will Use Its Cash Wisely
Nov 12Dyne Therapeutics' Q3 Preview: High-Risk, High-Reward Path In Muscle Diseases
Nov 11Dyne Therapeutics: Management Merry-Go-Round, Shaky Data Rock Wall Street
Sep 04Companies Like Dyne Therapeutics (NASDAQ:DYN) Are In A Position To Invest In Growth
Aug 14Dyne Therapeutics: Progress Undenied In DM1 And DMD Trials
May 21We're Not Very Worried About Dyne Therapeutics' (NASDAQ:DYN) Cash Burn Rate
May 04Dyne: H2 2024 Muscle Disease Data Could Boost Value
Mar 05We're Keeping An Eye On Dyne Therapeutics' (NASDAQ:DYN) Cash Burn Rate
Dec 05Here's Why We're Watching Dyne Therapeutics' (NASDAQ:DYN) Cash Burn Situation
Aug 09We're Keeping An Eye On Dyne Therapeutics' (NASDAQ:DYN) Cash Burn Rate
Mar 26We Think Dyne Therapeutics (NASDAQ:DYN) Needs To Drive Business Growth Carefully
Dec 10Is Dyne Therapeutics (NASDAQ:DYN) In A Good Position To Invest In Growth?
Aug 26Dyne wins regulatory nod to start trial for myotonic dystrophy candidate
Jul 12Dyne stock rises 12% as FDA lifts hold on starting muscle disorder study of DYNE-251
Jul 05Here's Why We're Watching Dyne Therapeutics' (NASDAQ:DYN) Cash Burn Situation
May 05We're Hopeful That Dyne Therapeutics (NASDAQ:DYN) Will Use Its Cash Wisely
Jan 12We Think Dyne Therapeutics (NASDAQ:DYN) Can Afford To Drive Business Growth
Sep 29Dyne Therapeutics' chief scientific officer Romesh Subramanian steps down
Jun 02Here's Why We're Not Too Worried About Dyne Therapeutics' (NASDAQ:DYN) Cash Burn Situation
May 12Dyne Therapeutics EPS beats by $0.10
May 06CEO
John Cox (61 yo)
less than a year
Görev süresi
Mr. John G. Cox, M.B.A. serves as Chief Executive Officer, President and Director at Dyne Therapeutics, Inc. from March 2024. He also serves as Atlas Advisor at Atlas Venture L.P. since 2024. He serves as...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
CEO, President & Director | less than a year | Veri yok | 0.036% $ 1.1m | |
Co-Founder & Advisor | no data | US$4.37m | Veri yok | |
Senior VP and Head of Finance & Administration | 4.3yrs | Veri yok | 0.0058% $ 172.6k | |
Chief Technical Officer | 1.6yrs | Veri yok | Veri yok | |
Chief Scientific Officer | 3.4yrs | US$1.49m | 0.033% $ 981.2k | |
Senior VP and Head of Corporate Communications & Investor Relations | 4.3yrs | Veri yok | Veri yok | |
Senior VP & Head of Legal | 4.4yrs | Veri yok | Veri yok | |
Chief Human Resource Officer | less than a year | Veri yok | Veri yok | |
Chief Regulatory Affairs Officer | 4.5yrs | Veri yok | Veri yok | |
Chief Medical Affairs Officer | 3.8yrs | Veri yok | Veri yok | |
Chief Commercial Officer | less than a year | Veri yok | Veri yok | |
Chief Medical Officer | less than a year | Veri yok | Veri yok |
3.4yrs
Ortalama Görev Süresi
56.5yo
Ortalama Yaş
Deneyimli Yönetim: DYN 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.4 yıldır).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
CEO, President & Director | less than a year | Veri yok | 0.036% $ 1.1m | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Independent Director | 6yrs | US$250.17k | 0% $ 0 | |
Independent Director | 4.7yrs | US$264.17k | 0.053% $ 1.6m | |
Independent Chairman | 6.9yrs | US$283.17k | 0% $ 0 | |
Independent Director | 6yrs | US$262.67k | 0% $ 0 | |
Member of Scientific Advisory Board | 4.3yrs | Veri yok | Veri yok | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Independent Director | 5.4yrs | US$253.92k | 0.088% $ 2.6m | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory Board | 4.5yrs | Veri yok | Veri yok |
5.0yrs
Ortalama Görev Süresi
61yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: DYN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5 yıldır).